Want to see IN:RAINBOW full AI Analyst Report?
RAINBOW Stock Chart & Stats
₹1348.80
-₹22.20(-1.36%)
At close: 4:00 PM EST
₹1348.80
-₹22.20(-1.36%)
Day’s Range― - ―
52-Week Range₹1,008.75 - ₹1,644.10
Previous CloseN/A
Volume60.55K
Average Volume (3M)8.91K
Market Cap
₹151.57B
Enterprise Value₹122.33K
Total Cash (Recent Filing)₹4.38B
Total Debt (Recent Filing)₹8.91B
Price to Earnings (P/E)54.4
Beta0.61
Next Earnings
Aug 10, 2026EPS Estimate
5.8Next Dividend Ex-DateN/A
Dividend Yield0.23%
Share Statistics
EPS (TTM)20.27
Shares Outstanding101,566,640
10 Day Avg. Volume4,219
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG Ratio2.96
Price to Book (P/B)7.17
Price to Sales (P/S)6.93
P/FCF Ratio86.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,689.50Price Target Upside25.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)32.5
Revenue Forecast (FY)₹19.95B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSteady revenue expansion from 2022–2026 indicates durable demand for pediatric and women’s healthcare. Consistent top-line growth supports better bed utilization, scale economics across facilities, and predictable cash flow that underpins medium-term capacity investments and operational planning.
Sustained ProfitabilityConsistently healthy operating and net margins (~16–18%) reflect a profitable service mix and pricing power in specialized pediatric/OB-GYN care. Margin durability enables internal funding for reinvestment, cushions against cost inflation, and supports sustainable cash generation over multiple cycles.
Improved Leverage & Balance SheetMaterial improvement in debt-to-equity from >1x to ~0.54x and consistent equity build enhance financial resilience. Lower relative leverage increases flexibility to fund network expansion, absorb volume dips, and pursue strategic investments without immediate refinancing pressure.
Bears Say
Volatile Free Cash FlowLarge swings in free cash flow—negative in 2024, strong in 2025, then sharply down in 2026—signal lumpy capex or working-capital cycles. This variability can constrain dividends, organic expansion, and debt servicing flexibility during weaker cash periods despite underlying operating profitability.
Gross Margin CompressionNotable gross margin compression in 2026 points to rising input costs, unfavorable case mix, or normalization after unusually high prior margins. If persistent, margin erosion could reduce operating leverage benefits and force price adjustments or cost containment that hurt long-term service quality or growth.
Rising Absolute DebtAlthough leverage ratios improved, absolute debt levels have increased, heightening exposure to interest-rate rises and refinancing risk. Higher nominal debt raises execution risk if volumes slow, potentially limiting capital allocation choices and increasing funding costs over the medium term.
Rainbow Childrens Medicare Limited News
RAINBOW FAQ
What was Rainbow Childrens Medicare Limited’s price range in the past 12 months?
Rainbow Childrens Medicare Limited lowest stock price was ₹1008.75 and its highest was ₹1644.10 in the past 12 months.
What is Rainbow Childrens Medicare Limited’s market cap?
Rainbow Childrens Medicare Limited’s market cap is ₹151.57B.
When is Rainbow Childrens Medicare Limited’s upcoming earnings report date?
Rainbow Childrens Medicare Limited’s upcoming earnings report date is Aug 10, 2026 which is in 19 days.
How were Rainbow Childrens Medicare Limited’s earnings last quarter?
Rainbow Childrens Medicare Limited released its earnings results on May 23, 2026. The company reported ₹7.6 earnings per share for the quarter, beating the consensus estimate of ₹6.35 by ₹1.25.
Is Rainbow Childrens Medicare Limited overvalued?
According to Wall Street analysts Rainbow Childrens Medicare Limited’s price is currently Undervalued.
Does Rainbow Childrens Medicare Limited pay dividends?
Rainbow Childrens Medicare Limited pays a Annually dividend of ₹3.5 which represents an annual dividend yield of 0.23%. See more information on Rainbow Childrens Medicare Limited dividends here
What is Rainbow Childrens Medicare Limited’s EPS estimate?
Rainbow Childrens Medicare Limited’s EPS estimate is 5.8.
How many shares outstanding does Rainbow Childrens Medicare Limited have?
Rainbow Childrens Medicare Limited has 101,566,640 shares outstanding.
What happened to Rainbow Childrens Medicare Limited’s price movement after its last earnings report?
Rainbow Childrens Medicare Limited reported an EPS of ₹7.6 in its last earnings report, beating expectations of ₹6.35. Following the earnings report the stock price went up 0.177%.
Which hedge fund is a major shareholder of Rainbow Childrens Medicare Limited?
Currently, no hedge funds are holding shares in IN:RAINBOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rainbow Childrens Medicare Limited
Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pediatrics, neonatology, various surgical disciplines, gastroenterology, hematology, oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, and psychiatric support. The company also delivers specialized care such as intensive care units, bone marrow and kidney transplants, cochlear implants, genetic and metabolic medicine, and therapeutic services like speech, language, and occupational therapy, alongside developmental and behavioral pediatrics. For women's health, Rainbow provides extensive obstetrics and gynecology services, including high-risk pregnancy management, painless delivery options, childbirth education, post-delivery support, well-woman check-ups, urogynecology, pre-pregnancy assessments, minimally invasive surgery, breast care, fetal medicine, and menopausal treatments. Furthermore, the company offers a full spectrum of fertility solutions, encompassing ovulation induction, various in-vitro fertilization techniques (such as ICSI and IMSI), intrauterine insemination, assisted hatching, cryopreservation, donor programs (sperm, oocyte, embryo), surgical sperm retrieval, and reproductive surgery. As of December 31, 2021, the company operated 14 hospitals and 3 clinics across 6 cities, providing a total of 1,500 beds. Established in 1998, its headquarters are situated in Hyderabad, India.
RAINBOW Stock 12 Month Forecast
Average Price Target
₹1,689.50
▲(25.26% Upside)
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―







